PLX logo

Protalix BioTherapeutics (PLX)

Profile

Full Name

Protalix BioTherapeutics, Inc.

Ticker Symbol

PLX

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 15, 1998

Indexes

Not included

Website

http://www.protalix.com

Employees

213

Key Details

Price

$2.94(-0.68%)

Market cap

$229.42M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$53.40M(-18.47% YoY)

Annual EPS

$0.04(-55.56% YoY)

PE ratio

98.00

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.94
PLX price is $2.94

30-Day Relative Volume

1.98
PLX 30-day relative volume is 1.98

Price Performance

Price Most recent change

-0.68%
PLX price was down -0.68% on Apr 24, 2025

Price YTD change

+56.38%
PLX price is up +56.38% since January 1st

Price 1-year change

+149.15%
PLX price is up +149.15% year-on-year

Price 3-year change

+153.45%
PLX price is up +153.45% over the past 3 years

Price Range

Price All-time high

$912.50
PLX price is currently -99.68% below its historical high of $912.50

Price 3-year low

$0.82
PLX price is currently +258.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$229.42M
PLX market capitalization is $229.42 million

Market cap 3-year change

+326.55%
PLX market capitalization is up +326.55% over the past 3 years

Market cap All-time high

$3.00B
PLX market capitalization is currently -92.36% below its historical high of $3.00 billion

Market cap sector rank

57.66%
PLX market capitalization is higher than 57.66% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.82%
PLX shares outstanding is up +6.82% year-on-year

Shares Outstanding 3-Year Change

+68.3%
PLX shares outstanding is up +68.3% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
PLX beta is 0.60

200-day SMA

$1.69
PLX price is currently +73.46% above its 200-day simple moving average

50-day SMA

$2.46
PLX price is currently +19.38% above its 50-day simple moving average

RSI

69.16
PLX 14-day relative strength index is 69.16

Volume

1.98
PLX 30-day relative volume is 1.98

ATR

$0.14
PLX average true range is $0.14

10-day Historical Volatility

77.06%
PLX 10-day historical volatility is 77.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$53.40M
PLX annual revenue is $53.40 million

Revenue Analysts estimate

$80.49M
PLX annual revenue is currently -33.66% lower than the consensus analysts' forecast

Revenue 1-year change

-18.47%
PLX annual revenue is down -18.47% year-on-year

Revenue Sector rank

46.99%
PLX annual revenue is higher than 46.99% of companies in Healthcare sector

EPS

EPS

$0.04
PLX annual earnings per share is $0.04

EPS Analysts estimate

-
PLX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-55.56%
PLX annual earnings per share is down -55.56% year-on-year

EPS Sector rank

82.72%
PLX annual earnings per share is higher than 82.72% of companies in Healthcare sector

Profit

Gross profit

$29.08M
PLX annual gross profit is $29.08 million

Gross margin

54.46%
PLX annual gross profit margin is 54.46%

Operating profit

$3.92M
PLX annual operating income is $3.92 million

Operating margin

7.34%
PLX annual operating profit margin is 7.34%

Net income

$2.93M
PLX annual net profit is $2.93 million

Net margin

5.49%
PLX annual net profit margin is 5.49%

Expenses

Total expenses

$49.48M
PLX annual total expenses is $49.48 million

Operating expenses

$25.16M
PLX annual total operating expenses is $25.16 million

Cost of goods sold

$24.32M
PLX annual cost of goods sold is $24.32 million

Selling, general & administrative expenses

$12.19M
PLX annual SGA is $12.19 million

Depreciation and amortization

$1.30M
PLX annual depreciation & amortization is $1.30 million

Interest expense

$1.06M
PLX annual interest expense is $1.06 million

Income tax

$1.22M
PLX annual income tax is $1.22 million

EBIT & EBITDA

EBIT

$5.22M
PLX annual earnings before interest & taxes is $5.22 million

EBITDA

$6.52M
PLX annual EBITDA is $6.52 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$73.42M
PLX annual total assets is $73.42 million

Non current assets

$13.34M
PLX annual long term assets is $13.34 million

Current assets

$60.08M
PLX annual total current assets is $60.08 million

Cash and cash equivalents

$19.76M
PLX annual cash & cash equivalents is $19.76 million

Accounts receivable

$2.91M
PLX annual accounts receivable is $2.91 million

Inventory

$21.24M
PLX annual inventory is $21.24 million

Liabilities

Total liabilities

$30.21M
PLX annual total liabilities is $30.21 million

Long term liabilities

$4.58M
PLX annual total long term liabilities is $4.58 million

Current liabilities

$25.62M
PLX annual total current liabilities is $25.62 million

Accounts payable

$4.53M
PLX annual accounts payable is $4.53 million

Debt

Total debt

$5.53M
PLX annual total debt is $5.53 million

Total debt 1-year change

-78.97%
PLX annual total debt is down -78.97% year-on-year

Long term debt

$4.03M
PLX annual long term debt is $4.03 million

Short term debt

$1.50M
PLX annual short term debt is $1.50 million

Equity & Capital

Shareholders equity

$43.21M
PLX annual stockholders equity is $43.21 million

Book value

$43.21M
PLX annual book value is $43.21 million

Retained earnings

-$378.39M
PLX annual retained earnings is -$378.39 million

Working capital

$34.46M
PLX annual working capital is $34.46 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$8.67M
PLX annual cash flow from operations is $8.67 million

Cash from operations 1-year change

+758.12%
PLX annual cash flow from operations is up +758.12% year-on-year

Cash from investing

$4.22M
PLX annual cash flow from investing activities is $4.22 million

Cash from investing 1-year change

+125.26%
PLX annual cash flow from investing activities is up +125.26% year-on-year

Cash from financing

-$16.79M
PLX annual cash flow from financing activities is -$16.79 million

Cash from financing 1-year change

-168.09%
PLX annual cash flow from financing activities is down -168.09% year-on-year

CAPEX

CAPEX

$1.28M
PLX annual capital expenditures is $1.28 million

CAPEX 1-year change

+11.58%
PLX annual capital expenditures is up +11.58% year-on-year

Free Cash Flow

Free cash flow

$7.39M
PLX annual free cash flow is $7.39 million

Free cash flow 1-year change

+399.64%
PLX annual free cash flow is up +399.64% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

54.46%
PLX annual gross profit margin is 54.46%

Operating margin

7.34%
PLX annual operating profit margin is 7.34%

Net margin

5.49%
PLX annual net profit margin is 5.49%

ROA & ROE

ROA

3.71%
PLX annual return on assets is 3.71%

ROE

7.64%
PLX annual return on equity is 7.64%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

98.00
PLX price to earnings ratio is 98.00

PE ratio Sector rank

90.2%
PLX price to earnings ratio is higher than 90.2% of companies in Healthcare sector

PB Ratio

PB ratio

5.31
PLX price to book ratio is 5.31

PB ratio Sector rank

83.24%
PLX price to book ratio is higher than 83.24% of companies in Healthcare sector

PS Ratio

PS ratio

4.30
PLX price to sales ratio is 4.30

PS ratio Sector rank

61.3%
PLX price to sales ratio is higher than 61.3% of companies in Healthcare sector

Enterprise value

Enterprise value

$215.18M
PLX enterprise value is $215.18 million

Enterprise value Sector rank

58.3%
PLX enterprise value is higher than 58.3% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

33.00
PLX EV/EBITDA is 33.00

EV/EBITDA Sector rank

95.07%
PLX EV/EBITDA is higher than 95.07% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.34
PLX annual current ratio is 2.34

Quick ratio

1.52
PLX annual quick ratio is 1.52

Leverage

Debt to equity

0.00
PLX annual debt to equity ratio is 0.00

Interest coverage ratio

4.91
PLX annual interest coverage ratio is 4.91

Risk & Stability

Piotroski F-Score

7
PLX piotroski f-score is 7

Altman Z-Score

-1.13
PLX altman z-score is -1.13

Analyst ratings

Recent major analysts updates

Feb 3, 25 HC Wainwright & Co.
Buy
Nov 14, 23 HC Wainwright & Co.
Buy
Oct 31, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

PRME logo
Prime Medicine (PRME)
HUMA logo
Humacyte (HUMA)
LFCR logo
Lifecore Biomedical (LFCR)
AMRN logo
Amarin (AMRN)
THRD logo
Third Harmonic Bio (THRD)
OSUR logo
OraSure Technologies (OSUR)
DCGO logo
DocGo (DCGO)
CGC logo
Canopy Growth (CGC)
Alumis (ALMS)
  • What is the ticker symbol for Protalix BioTherapeutics?
  • Does Protalix BioTherapeutics pay dividends?
  • What sector is Protalix BioTherapeutics in?
  • What industry is Protalix BioTherapeutics in?
  • What country is Protalix BioTherapeutics based in?
  • When did Protalix BioTherapeutics go public?
  • Is Protalix BioTherapeutics in the S&P 500?
  • Is Protalix BioTherapeutics in the NASDAQ 100?
  • Is Protalix BioTherapeutics in the Dow Jones?
  • When was Protalix BioTherapeutics's last earnings report?
  • When does Protalix BioTherapeutics report earnings?
  • Should I buy Protalix BioTherapeutics stock now?

What is the ticker symbol for Protalix BioTherapeutics?

The ticker symbol for Protalix BioTherapeutics is NYSE American:PLX

Does Protalix BioTherapeutics pay dividends?

No, Protalix BioTherapeutics does not pay dividends

What sector is Protalix BioTherapeutics in?

Protalix BioTherapeutics is in the Healthcare sector

What industry is Protalix BioTherapeutics in?

Protalix BioTherapeutics is in the Biotechnology industry

What country is Protalix BioTherapeutics based in?

Protalix BioTherapeutics is headquartered in United States

When did Protalix BioTherapeutics go public?

Protalix BioTherapeutics's initial public offering (IPO) was on May 15, 1998

Is Protalix BioTherapeutics in the S&P 500?

No, Protalix BioTherapeutics is not included in the S&P 500 index

Is Protalix BioTherapeutics in the NASDAQ 100?

No, Protalix BioTherapeutics is not included in the NASDAQ 100 index

Is Protalix BioTherapeutics in the Dow Jones?

No, Protalix BioTherapeutics is not included in the Dow Jones index

When was Protalix BioTherapeutics's last earnings report?

Protalix BioTherapeutics's most recent earnings report was on Mar 17, 2025

When does Protalix BioTherapeutics report earnings?

The next expected earnings date for Protalix BioTherapeutics is May 9, 2025

Should I buy Protalix BioTherapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page